Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jan 05, 2026

SELL
$1.05 - $1.63 $78 - $122
-75 Closed
0 $0
Q1 2023

Jan 05, 2026

BUY
$1.2 - $2.73 $90 - $204
75 New
75 $101,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Chesapeake Asset Management LLC Portfolio

Follow Chesapeake Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Asset Management LLC with notifications on news.